2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Gline Matthew | — | 38,847,462 | Mar 6, 2025 |
| Ramaswamy Vivek | — | 16,068,455 | Mar 16, 2015 |
| Viking Global Equities Master Ltd. | — | 16,013,540 | Jan 10, 2019 |
| Dexcel Pharma Technologies Ltd. | — | 16,013,540 | Oct 18, 2017 |
| SVF Investments (UK) Ltd | — | 16,013,540 | Sep 14, 2017 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 2, 2026 | Nguyen Tuan | CFO | Neutral | 90.0 | +73,500 | 100.00% | ✗ | - |
| Feb 2, 2026 | Feb 2, 2026 | Androski Lindsay | CEO | Neutral | 90.0 | +28,000 | 100.00% | ✗ | - |
| Aug 4, 2025 | Aug 6, 2025 | Sawhney Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 6, 2025 | Sawhney Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 31, 2025 | Apr 1, 2025 | Nguyen Tuan | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 31, 2025 | Mar 31, 2025 | Nguyen Tuan | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 31, 2025 | Nguyen Tuan | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 18, 2025 | Mar 20, 2025 | Hasija Anuj | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 18, 2025 | Mar 20, 2025 | Beardsley Robert A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 18, 2025 | Mar 20, 2025 | Androski Lindsay | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 6, 2025 | Hasija Anuj | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 6, 2025 | Bishop Joseph E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 6, 2025 | Beardsley Robert A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 6, 2025 | Androski Lindsay | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 6, 2025 | Gline Matthew | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 14, 2025 | Feb 19, 2025 | Naftzger J. Christopher | General Counsel and CCO | Neutral | 90.0 | +54,300 | 62.96% | ✗ | - |
| Feb 14, 2025 | Feb 19, 2025 | McElhaugh Michael J. | CEO | Neutral | 90.0 | +177,000 | 11.95% | ✗ | - |
| Feb 14, 2025 | Feb 19, 2025 | HASTINGS DAVID C | CFO | Neutral | 90.0 | +90,100 | 56.41% | ✗ | - |
| Feb 14, 2025 | Feb 19, 2025 | Sims Karen | Chief Medical Officer | Neutral | 90.0 | +49,300 | 46.42% | ✗ | - |
| Feb 4, 2025 | Feb 5, 2025 | HASTINGS DAVID C | CFO | Sell | 25.0 | -22,183 | -12.19% | ✓ | $72.8K |
| Feb 4, 2025 | Feb 5, 2025 | Sims Karen | Chief Medical Officer | Sell | 20.0 | -19,348 | -15.41% | ✓ | $63.5K |
| Feb 4, 2025 | Feb 5, 2025 | McElhaugh Michael J. | CEO | Sell | 45.0 | -23,790 | -1.58% | ✓ | $78.1K |
| Feb 4, 2025 | Feb 5, 2025 | Naftzger J. Christopher | General Counsel and CCO | Sell | 28.8 | -11,333 | -11.61% | ✓ | $37.2K |
| Aug 14, 2024 | Aug 16, 2024 | MANCHESTER KEITH S | Director | Sell | 26.3 | -8,846 | -16.11% | ✗ | $32.6K |
| May 23, 2024 | May 24, 2024 | BURGESS DANIEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 23, 2024 | May 24, 2024 | MANCHESTER KEITH S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 23, 2024 | May 24, 2024 | HENRIQUES RICHARD C JR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 23, 2024 | May 24, 2024 | Meyers James R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 23, 2024 | May 24, 2024 | Rewolinski Melissa | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 23, 2024 | May 24, 2024 | Torti Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | Naftzger J. Christopher | General Counsel and CCO | Neutral | 90.0 | +95,100 | 100.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | Sims Karen | Chief Medical Officer | Sell | 91.3 | +96,642 | 334.40% | ✓ | $10.1K |
| Feb 1, 2024 | Feb 5, 2024 | HASTINGS DAVID C | CFO | Sell | 91.3 | +102,907 | 130.26% | ✓ | $22.2K |
| Feb 1, 2024 | Feb 5, 2024 | Sofia Michael J. | Chief Scientific Officer | Sell | 86.3 | +99,518 | 6.41% | ✓ | $23.1K |
| Feb 1, 2024 | Feb 5, 2024 | McElhaugh Michael J. | CEO | Sell | 86.3 | +113,636 | 8.17% | ✓ | $23.5K |
| Jul 12, 2023 | Jul 13, 2023 | Rewolinski Melissa | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 13, 2023 | Rewolinski Melissa | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 10, 2023 | Jul 12, 2023 | Sims Karen | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 12, 2023 | Sims Karen | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 10, 2023 | Jul 12, 2023 | Naftzger J. Christopher | General Counsel and CCO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 12, 2023 | Naftzger J. Christopher | General Counsel and CCO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 24, 2023 | May 26, 2023 | HENRIQUES RICHARD C JR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 24, 2023 | May 26, 2023 | BURGESS DANIEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 24, 2023 | May 26, 2023 | MANCHESTER KEITH S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 24, 2023 | May 26, 2023 | Torti Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 24, 2023 | May 26, 2023 | Meyers James R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2023 | Feb 3, 2023 | McElhaugh Michael J. | Chief Business Officer | Neutral | 85.0 | +83,700 | 6.40% | ✗ | - |
| Feb 1, 2023 | Feb 3, 2023 | Sofia Michael J. | Chief Scientific Officer | Neutral | 85.0 | +82,200 | 5.59% | ✗ | - |
| Feb 1, 2023 | Feb 3, 2023 | HASTINGS DAVID C | CFO | Neutral | 90.0 | +79,000 | 100.00% | ✗ | - |
| Feb 1, 2023 | Feb 3, 2023 | Collier William H. | CEO | Neutral | 90.0 | +216,500 | 100.00% | ✗ | - |
| Feb 1, 2023 | Feb 3, 2023 | Howard Elizabeth | EVP, GC, Compliance | Neutral | 90.0 | +69,700 | 426.98% | ✗ | - |
| May 25, 2022 | May 26, 2022 | HENRIQUES RICHARD C JR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2022 | May 26, 2022 | BURGESS DANIEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2022 | May 26, 2022 | Meyers James R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2022 | May 26, 2022 | Torti Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2022 | May 26, 2022 | Tran Tram | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2022 | May 26, 2022 | MANCHESTER KEITH S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2022 | Jan 20, 2022 | Collier William H. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2022 | Jan 20, 2022 | HASTINGS DAVID C | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2022 | Jan 20, 2022 | Howard Elizabeth | Chief Compliance Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2022 | Jan 20, 2022 | Sofia Michael J. | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2022 | Jan 20, 2022 | Picchio Gaston | Chief Development Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2022 | Jan 20, 2022 | McElhaugh Michael J. | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 1, 2021 | Dec 3, 2021 | Sofia Michael J. | Chief Scientific Officer | Sell | 20.0 | -200,000 | -11.97% | ✓ | $1M |
| Nov 9, 2021 | Nov 12, 2021 | Tran Tram | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 12, 2021 | Tran Tram | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 3, 2021 | Jun 7, 2021 | BURGESS DANIEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2021 | Jun 7, 2021 | HENRIQUES RICHARD C JR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2021 | Jun 7, 2021 | Meyers James R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2021 | Jun 7, 2021 | MANCHESTER KEITH S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2021 | Jun 7, 2021 | Cheng Andrew | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2021 | Jun 7, 2021 | Torti Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 13, 2021 | Feb 17, 2021 | Picchio Gaston | Chief Development Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 13, 2021 | Feb 17, 2021 | HASTINGS DAVID C | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 13, 2021 | Feb 17, 2021 | Collier William H. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 13, 2021 | Feb 17, 2021 | Howard Elizabeth | Chief Compliance Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 13, 2021 | Feb 17, 2021 | McElhaugh Michael J. | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 13, 2021 | Feb 17, 2021 | Sofia Michael J. | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2021 | Feb 10, 2021 | McElhaugh Michael J. | Chief Business Officer | Sell | 45.0 | -20,000 | -1.51% | ✓ | $100K |
| Dec 14, 2020 | Dec 16, 2020 | McElhaugh Michael J. | Chief Business Officer | Sell | 41.3 | -40,000 | -2.93% | ✓ | $200K |
| Sep 23, 2020 | Sep 25, 2020 | Picchio Gaston | Chief Development Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 23, 2020 | Sep 25, 2020 | Collier William H. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 23, 2020 | Jul 27, 2020 | McElhaugh Michael J. | Chief Business Officer | Sell | 45.0 | -20,000 | -1.44% | ✓ | $100.2K |
| May 28, 2020 | Jun 1, 2020 | Meyers James R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2020 | Jun 1, 2020 | HENRIQUES RICHARD C JR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2020 | Jun 1, 2020 | Collier William H. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2020 | Jun 1, 2020 | Torti Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2020 | Jun 1, 2020 | Cheng Andrew | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2020 | Jun 1, 2020 | MANCHESTER KEITH S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2020 | Jun 1, 2020 | BURGESS DANIEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2020 | Feb 19, 2020 | Howard Elizabeth | Chief Compliance Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2020 | Feb 19, 2020 | Sofia Michael J. | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2020 | Feb 19, 2020 | Picchio Gaston | Chief Development Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2020 | Feb 19, 2020 | Collier William H. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2020 | Feb 19, 2020 | HASTINGS DAVID C | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2020 | Feb 19, 2020 | McElhaugh Michael J. | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 19, 2020 | Venker Eric | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 17, 2019 | Aug 20, 2019 | Cheng Andrew | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 17, 2019 | Aug 20, 2019 | POTTER MYRTLE S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 20, 2019 | Cheng Andrew | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |